Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003504 |
---|---|
Receipt number | R000004239 |
Scientific Title | Phase I clinical trial of WT1 peptide-based vaccine combined with Temozoromide for patients with malignant glioma. |
Date of disclosure of the study information | 2010/04/19 |
Last modified on | 2014/11/27 15:41:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/04/19 12:11:04 | ||
2 | Update | 2011/06/09 13:45:58 | Recruitment status |
|
3 | Update | 2013/04/19 14:13:55 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2014/11/27 15:41:15 | Email |
|
5 | Update | 2014/11/27 15:41:45 | Recruitment status Last follow-up date |